Insurance, Health, Accident - As introduced, requires certain insurers with policies or contracts that provide coverage for Veklury (remdesivir) to also provide coverage for monoclonal antibody infusions and budesonide treatment at a cost to the insured no greater than the cost of Veklury (remdesivir) to the insured on or after July 1, 2022. - Amends TCA Title 8; Title 56 and Title 71.
Bill status
died
1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
Governor
Introduced Jan 31, 2022
Last action Feb 25, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
2
Committee
2
Feb 25, 2022
Upper · Passed
Recalled from Senate Commerce & Labor Committee
upper
Feb 3, 2022
Upper · Passed
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
upper
Feb 2, 2022
Introduced
Introduced, Passed on First Consideration
upper
Jan 31, 2022
Introduced
Filed for introduction
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mark Pody
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 2097
Scope: TN
Hi! I can help you understand SB 2097. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline